1. Home
  2. ORC vs SYRE Comparison

ORC vs SYRE Comparison

Compare ORC & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORC
  • SYRE
  • Stock Information
  • Founded
  • ORC 2010
  • SYRE 2013
  • Country
  • ORC United States
  • SYRE United States
  • Employees
  • ORC N/A
  • SYRE N/A
  • Industry
  • ORC Real Estate Investment Trusts
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORC Real Estate
  • SYRE Health Care
  • Exchange
  • ORC Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • ORC 1.2B
  • SYRE 1.1B
  • IPO Year
  • ORC 2013
  • SYRE 2016
  • Fundamental
  • Price
  • ORC $7.21
  • SYRE $24.66
  • Analyst Decision
  • ORC Hold
  • SYRE Strong Buy
  • Analyst Count
  • ORC 2
  • SYRE 4
  • Target Price
  • ORC N/A
  • SYRE $52.67
  • AVG Volume (30 Days)
  • ORC 6.2M
  • SYRE 672.4K
  • Earning Date
  • ORC 10-23-2025
  • SYRE 11-04-2025
  • Dividend Yield
  • ORC 20.00%
  • SYRE N/A
  • EPS Growth
  • ORC N/A
  • SYRE N/A
  • EPS
  • ORC 0.57
  • SYRE N/A
  • Revenue
  • ORC $80,187,000.00
  • SYRE N/A
  • Revenue This Year
  • ORC $82.99
  • SYRE N/A
  • Revenue Next Year
  • ORC $61.79
  • SYRE N/A
  • P/E Ratio
  • ORC $12.55
  • SYRE N/A
  • Revenue Growth
  • ORC 5.93
  • SYRE N/A
  • 52 Week Low
  • ORC $5.69
  • SYRE $10.91
  • 52 Week High
  • ORC $9.01
  • SYRE $29.09
  • Technical
  • Relative Strength Index (RSI)
  • ORC 45.80
  • SYRE 62.04
  • Support Level
  • ORC $7.08
  • SYRE $22.13
  • Resistance Level
  • ORC $7.26
  • SYRE $25.42
  • Average True Range (ATR)
  • ORC 0.12
  • SYRE 1.50
  • MACD
  • ORC -0.03
  • SYRE -0.09
  • Stochastic Oscillator
  • ORC 31.08
  • SYRE 83.39

About ORC Orchid Island Capital Inc.

Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: